or Try an Advanced Search...

    Enzyme Replacement Therapies Stocks List

    Symbol Grade Name % Change
    SNY C Sanofi -0.31
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Animal Health Cac 40 Cancer Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Dialysis Fever Gaucher Disease Glucose Glucose Meter Health Care Products Health Sciences Healthcare Products Hepatotoxins Hypertension Influenza

    Related ETFs - A few ETFs which own one or more of the above listed Enzyme Replacement Therapies stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 4.78
    VIRS B Pacer BioThreat Strategy ETF 4.29
    PID A PowerShares Intl Dividend Achievers 2.93
    MEDI D Harbor Health Care ETF 2.83
    PVAL A Putnam Focused Large Cap Value ETF 2.27
    View all Enzyme Replacement Therapies ETFs...
    Compare ETFs
    Compare PID to PVAL Compare PPH to PID Compare PPH to VIRS

        Enzyme Replacement Therapies Stocks Recent News

        Date Stock Title
        May 17 SNY The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
        May 17 SNY Could Novavax Become the Next Moderna?
        May 16 SNY Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
        May 16 SNY Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
        May 16 SNY If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
        May 15 SNY Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
        May 15 SNY Novavax Stock Just Tripled. Is It Too Late to Buy?
        May 14 SNY Sanofi to make €1bn biomanufacturing investment in France
        May 14 SNY Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
        May 14 SNY Trending tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax
        May 14 SNY Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
        May 14 SNY Exploring Three Dividend Stocks On Euronext Paris
        May 13 SNY Barrow, Hanley, Mewhinney & Strauss Bolsters Portfolio with Strategic Additions in Q1 2024
        May 13 SNY Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
        May 13 SNY Meme Mania is Back: Buy these 3 Stocks
        May 13 SNY Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector
        May 13 SNY Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
        May 13 SNY Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
        May 13 SNY Sanofi gains license for ex-U.S. rights to Fulcrum muscular dystrophy candidate
        May 13 SNY Biggest stock movers today: ARM, ZK, TME, GME, and more
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Animal Health Cac 40 Cancer Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Dialysis Fever Gaucher Disease Glucose Glucose Meter Health Care Products Health Sciences Healthcare Products Hepatotoxins Hypertension Influenza
        Enzyme Replacement Therapies

        Enzyme Replacement Therapies (ERT) is a type of treatment used to treat certain genetic diseases caused by a lack of specific enzymes in the body. This type of therapy involves replacing the missing enzyme with a synthetic version, which can help restore normal functioning of the body. ERT is used to treat diseases such as Gaucher disease, Fabry disease, and Pompe disease.

        Browse All Tags